Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Apo B/Apo A-I Ratio is Statistically A Better Predictor of Cardiovascular Disease (CVD) than Conventional Lipid Profile: A Study from Kathmandu Valley, Nepal.

Tamang HK, Timilsina U, Singh KP, Shrestha S, Raman RK, Panta P, Karna P, Khadka L, Dahal C.

J Clin Diagn Res. 2014 Feb;8(2):34-6. doi: 10.7860/JCDR/2014/7588.4000. Epub 2014 Feb 3.

2.

Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.

Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan L, Keyes MJ, Pencina MJ, Schoonmaker C, Wilson PW, D'Agostino RB, Vasan RS.

JAMA. 2007 Aug 15;298(7):776-85.

PMID:
17699011
3.
4.
5.

Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.

Yilmaz M, Biri A, Bukan N, Karakoç A, Sancak B, Törüner F, Paşaoğlu H.

Gynecol Endocrinol. 2005 May;20(5):258-63.

PMID:
16019370
6.

Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels.

Leroux G, Lemieux I, Lamarche B, Cantin B, Dagenais GR, Lupien PJ, Després JP.

Metabolism. 2000 Jan;49(1):53-61.

PMID:
10647064
7.
8.

Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.

Kim HK, Chang SA, Choi EK, Kim YJ, Kim HS, Sohn DW, Oh BH, Lee MM, Park YB, Choi YS.

Int J Cardiol. 2005 Jun 8;101(3):435-40.

PMID:
15907412
9.

Hierarchical modelling of blood lipids' profile and 10-year (2002-2012) all cause mortality and incidence of cardiovascular disease: the ATTICA study.

Nomikos T, Panagiotakos D, Georgousopoulou E, Metaxa V, Chrysohoou C, Skoumas I, Antonopoulou S, Tousoulis D, Stefanadis C, Pitsavos C; ATTICA Study group.

Lipids Health Dis. 2015 Sep 15;14:108. doi: 10.1186/s12944-015-0101-7.

10.

Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.

Navarro JF, Mora C, Muros M, García-Idoate G.

Nephron Clin Pract. 2003;95(4):c128-35.

PMID:
14694274
11.
12.

Evaluation of non-HDL-c and total cholesterol: HDL-c ratio as cumulative marker of cardiovascular risk in diabetes mellitus.

Aryal M, Poudel A, Satyal B, Gyawali P, Pokharel BR, Raut BK, Adhikari RK, Koju R.

Kathmandu Univ Med J (KUMJ). 2010 Oct-Dec;8(32):398-404.

PMID:
22610769
13.
14.

Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk.

van der Steeg WA, Boekholdt SM, Stein EA, El-Harchaoui K, Stroes ES, Sandhu MS, Wareham NJ, Jukema JW, Luben R, Zwinderman AH, Kastelein JJ, Khaw KT.

Ann Intern Med. 2007 May 1;146(9):640-8.

PMID:
17470832
15.
16.

Non-high density lipoprotein cholesterol versus low density lipoprotein cholesterol as a discriminating factor for myocardial infarction.

Sigdel M, Yadav BK, Gyawali P, Regmi P, Baral S, Regmi SR, Jha B.

BMC Res Notes. 2012 Nov 17;5:640. doi: 10.1186/1756-0500-5-640.

18.

Postprandial lipoprotein responses in hypertriglyceridemic subjects with and without cardiovascular disease.

Hughes TA, Elam MB, Applegate WB, Bond MG, Hughes SM, Wang X, Tolley EA, Bittle JB, Stentz FB, Kang ES.

Metabolism. 1995 Aug;44(8):1082-98.

PMID:
7637651
19.

Increased lipoprotein (a) and its relationships with other parameters of lipoprotein metabolism in chronic renal failure treated by hemodialysis.

Yiğitoğlu MR, Polat MF, Akçay F, Ari Z, Uyanik BS, Ozilgili HM.

Jpn Heart J. 1997 Jan;38(1):83-9.

PMID:
9186284
20.

Assessment of adiponectin level in obese and lean Nepalese population and its possible correlation with lipid profile: A cross-sectional study.

Tamang HK, Timilsina U, Singh KP, Shrestha S, Pandey B, Basnet S, Waiba B, Shrestha U.

Indian J Endocrinol Metab. 2013 Oct;17(Suppl 1):S349-54. doi: 10.4103/2230-8210.119618.

Supplemental Content

Support Center